Literature DB >> 1554485

Effect of interferon-alpha on measles virus replication in human peripheral blood mononuclear cells.

R Leopardi1, T Hyypiä, R Vainionpää.   

Abstract

We analyzed the effect of exogenous human leukocyte interferon (IFN)-alpha on measles virus (MV) replication in human peripheral blood mononuclear cells (PBMC). The release of infectious virus was progressively reduced by increasing concentrations of IFN-alpha, and blocked with an IFN-alpha concentration of 1000 U/ml. In order to detect a possible target of this inhibitory effect, viral transcription and translation events were analyzed. The synthesis of MV mRNAs was reduced, but not blocked, in the presence of IFN-alpha. However, this effect was not specific on the viral RNAs, but due to a general inhibition of RNA synthesis in IFN-treated PBMC. The expression of viral polypeptides was also inhibited in a dose-dependent manner by exogenous IFN-alpha, but a low level of protein synthesis was detected by both Western blotting and immunofluorescence techniques, even with the maximum amount of IFN-alpha used (1000 U/ml). These findings account for a partial maintenance of the viral replicative cycle, even when the production of infectious virus is blocked. Moreover, the effect of IFN-alpha is not specifically targeted on the virus macromolecular synthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554485     DOI: 10.1111/j.1699-0463.1992.tb00850.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

Review 1.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

2.  Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon.

Authors:  Y Katayama; A Hirano; T C Wong
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

Authors:  Anna H Malczyk; Alexandra Kupke; Steffen Prüfer; Vivian A Scheuplein; Stefan Hutzler; Dorothea Kreuz; Tim Beissert; Stefanie Bauer; Stefanie Hubich-Rau; Christiane Tondera; Hosam Shams Eldin; Jörg Schmidt; Júlia Vergara-Alert; Yasemin Süzer; Janna Seifried; Kay-Martin Hanschmann; Ulrich Kalinke; Susanne Herold; Ugur Sahin; Klaus Cichutek; Zoe Waibler; Markus Eickmann; Stephan Becker; Michael D Mühlebach
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

4.  Human CD46 enhances nitric oxide production in mouse macrophages in response to measles virus infection in the presence of gamma interferon: dependence on the CD46 cytoplasmic domains.

Authors:  A Hirano; Z Yang; Y Katayama; J Korte-Sarfaty; T C Wong
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 5.  Measles virus-induced suppression of immune responses.

Authors:  Diane E Griffin
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

6.  MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line.

Authors:  J J Schnorr; S Schneider-Schaulies; A Simon-Jödicke; J Pavlovic; M A Horisberger; V ter Meulen
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Cell-cell fusion induced by measles virus amplifies the type I interferon response.

Authors:  F Herschke; S Plumet; T Duhen; O Azocar; J Druelle; D Laine; T F Wild; C Rabourdin-Combe; D Gerlier; H Valentin
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

8.  Measles virus spread and pathogenesis in genetically modified mice.

Authors:  B Mrkic; J Pavlovic; T Rülicke; P Volpe; C J Buchholz; D Hourcade; J P Atkinson; A Aguzzi; R Cattaneo
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

9.  Immature CD4+CD8+ thymocytes are preferentially infected by measles virus in human thymic organ cultures.

Authors:  Yukari Okamoto; Luca A Vricella; William J Moss; Diane E Griffin
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.